Back
Myriad Genetics Vs. Bright Minds Biosciences Industry Stock Comparison
Sell
33
MYGN
Myriad Genetics
Last Price:
23.96
Seasonality Move:
11.19%
Sell
50
DRUG
Bright Minds Biosciences
Last Price:
24.59
Seasonality Move:
-16.97%
Sell
33
Myriad Genetics (MYGN)
is a Sell
Is Myriad Genetics a Buy, Sell or Hold?
- The current Myriad Genetics [MYGN] share price is $23.97. The Score for MYGN is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- MYGN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
Bright Minds Biosciences (DRUG)
is a Sell
Is Bright Minds Biosciences a Buy, Sell or Hold?
- The current Bright Minds Biosciences [DRUG] share price is $37.50. The Score for DRUG is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- DRUG is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MYGN Stock Price Chart
What is Myriad Genetics's stock price today?
-
The Myriad Genetics share price today is $23.97
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MYGN is experiencing selling pressure, which indicates risk of future bearish movement.
DRUG Stock Price Chart
What is Bright Minds Biosciences's stock price today?
-
The Bright Minds Biosciences share price today is $37.50
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DRUG is experiencing buying pressure, which is a positive indicator for future bullish movement.
MYGN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.8 | Sell |
Relative Strength Index (14 RSI): | 37.84 | Sell |
Chaikin Money Flow: | -574874 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (25.03 - 27.81) | Sell |
Bollinger Bands (100): | (24.03 - 27.87) | Sell |
DRUG Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.97 | Buy |
Relative Strength Index (14 RSI): | 99.34 | Buy |
Chaikin Money Flow: | 96570542 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (-4.43 - 9.79) | Buy |
Bollinger Bands (100): | (-2.12 - 5.12) | Buy |
MYGN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 24.9 | Sell |
20-day SMA: | 26.19 | Sell |
50-day SMA: | 26.99 | Sell |
200-day SMA: | 23.62 | Buy |
8-day EMA: | 24.83 | Sell |
20-day EMA: | 25.78 | Sell |
50-day EMA: | 26.33 | Sell |
200-day EMA: | 24.12 | Sell |
DRUG Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.82 | Buy |
20-day SMA: | 3.04 | Buy |
50-day SMA: | 1.89 | Buy |
200-day SMA: | 1.51 | Buy |
8-day EMA: | 9.43 | Buy |
20-day EMA: | 4.72 | Buy |
50-day EMA: | 2.62 | Buy |
200-day EMA: | 1.76 | Buy |
Myriad Genetics Earnings Growth & MYGN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.40 per share, and an increase next year of $0.18 per share.
Bright Minds Biosciences Earnings Growth & DRUG Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Myriad Genetics Technical Analysis
Oct 2 | Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
02 | 03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Bright Minds Biosciences Technical Analysis
Oct 2 | Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
02 | 03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |